GAVeCeLT bundle for PICC-port insertion

“This paper describes an insertion bundle-developed by GAVeCeLT, the Italian Group of Long Term Venous Access Devices, and nicknamed “SIP-Port” (Safe Insertion of PICC-Ports)-which consists of few evidence-based strategies aiming to further minimize all immediate, early, or late complications potentially associated with PICC-port insertion” Brescia et al (2023).

Read More »

IV fluid administration in pediatric patients

“For pediatric patients, the demand for quality and safe Intravenous Fluid (IVF) therapy is huge. This is because, compared to adults, children have a lower tolerance for IVF therapy errors and present devastating physiological responses to errors” Grace and Efua (2023).

Read More »

Unplanned PICC removal – Full Text

“In this study, peripherally inserted central catheters with a proximal valve had a higher risk of unplanned removals, especially in patients without cancer. The peripherally inserted central catheter type should be considered in advance, and clinical staff should take appropriate measures to prevent unplanned removals after insertion” Yu et al (2023).

Read More »

OPAT implementation bundle

“Within a Belgian, single, large community-based hospital, a multimodal intervention bundle resulted in increases in OPAT implementation, infection complexity, and required treatment durations without statistically significant differences in outcomes” Missiaen et al (2023).

Read More »

Unplanned PICC removal – Full Text

“In this study, peripherally inserted central catheters with a proximal valve had a higher risk of unplanned removals, especially in patients without cancer. The peripherally inserted central catheter type should be considered in advance, and clinical staff should take appropriate measures to prevent unplanned removals after insertion” Yu et al (2023).

Read More »

OPAT implementation bundle

“Within a Belgian, single, large community-based hospital, a multimodal intervention bundle resulted in increases in OPAT implementation, infection complexity, and required treatment durations without statistically significant differences in outcomes” Missiaen et al (2023).

Read More »

Neonatal adverse drug reactions

“Neonates hospitalized in Neonatal Intensive Care Unit (NICU) commonly experience Adverse Drug Reactions (ADR). Thus, we aimed to develop and validate a tool for predicting ADRs in neonates hospitalized in NICUs” Duarte Leopoldino et al (2023).

Read More »

CRBSI prevention e-learning platform – Full Text

“This study aims to assess intensive care unit (ICU) nurses’ and physicians’ knowledge regarding the Centers for Disease Control and Prevention (CDC) guidelines for preventing CVC-related infections before and after an interactive distance education delivered through the e-learning platform Teleprometheus” Foka et al (2023).

Read More »

OPAT osteomyelitis treatment – Full Text

“He was successfully treated with surgical debridement combined with the administration of teicoplanin plus rifampicin in the outpatient setting, completing, in total, a twelve-week course of antibiotic therapy” Papaetis et al (2023).

Read More »

Patient experience of hyperemesis gravidarum

“Infusion nurses are in a perfect position to provide support and compassionate care for women who are repeatedly coming to the hospital for rehydration treatment. Infusion nurses can validate women’s physical and emotional struggles with hyperemesis gravidarum and help to no longer make women feel stigmatized” Beck et al (2023).

Read More »

Guidelines for natalizumab treatment

“This includes information on strategies to mitigate the risk of progressive multifocal leukoencephalopathy in natalizumab-treated patients, natalizumab use during pregnancy, and use with vaccines” O’Leary et al (2023).

Read More »

Impact of COVID-19 on CLABSI rates – Full Text

“The COVID-19 pandemic significantly impacted CLABSI incidence/rates. Observations from the different studies highlight significant gaps in healthcare associated infections (HCAI) knowledge and practice during the pandemic, and the importance of identifying preventive measures effective in reducing CLABSI, essential to health system resilience for future pandemics” Satta et al (2023).

Read More »

Near infrared vein visualization technology for peripheral IV access

“In a survey sent to facilities utilizing nIR technology, 48% of respondents incorporated nIR in nurse-driven protocols. Of these respondents, 88% reported improvement in patient satisfaction, 92% saw a reduction in escalations, and 79% reported a reduction in hospital-acquired infections associated with PIVC placement” Fraifeld and Thompson (2023).

Read More »

Pediatric CLABSI-free care

“Extended periods of CLABSI-free care in a pediatric hematology/oncology unit are achievable. A variety of factors contribute to the sustainability of being CLABSI-free. Data collection and analysis are important factors which aided in our understanding of our own CLABSI events” Thompson and Shaheen (2023).

Read More »

Neonatal chlorhexidine skin disinfection study – Full Text

“To inform the feasibility and design of a definitive randomised controlled trial (RCT) of two antiseptic formulations, we conducted the Antiseptic Randomised Controlled Trial for Insertion of Catheters (ARCTIC) feasibility study to assess catheter colonisation, sepsis, and skin morbidity” Clarke et al (2023).

Read More »

Pediatric medication errors – Full Text

“Preventive risk management should be targeted on high-alert medications in paediatric hospital settings. In these actions, the use of intravenous drugs, such as parenteral nutrition, concentrated electrolytes, analgesics and antineoplastic agents, and off-label use of medications should be prioritised” Kuitunen et al (2023).

Read More »